Tokyo, March 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060889) titled 'Evaluation of an AI-assisted chat system for patient inquiries after total hip arthroplasty' on March 10.
Study Type:
Observational
Primary Sponsor:
Institute - Hokusuikai Kinen Hospital
Condition:
Condition - Patients undergoing total hip arthroplasty (THA)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to evaluate the effectiveness, safety, and acceptability of an AI-assisted chat system integrated into a smartphone application designed to support patients undergoing total hip arthroplasty (THA).
The study will examine whether the AI system can reduce the workload of healthcare professionals by automatically responding to patient inquiries while maintaining medical appropriateness and patient satisfaction.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who:
- Undergo total hip arthroplasty at the participating institution
- Use the smartphone application for perioperative rehabilitation support
- Provide informed consent for participation in the study
Key exclusion criteria - Patients who:
- Are unable to use a smartphone application
- Decline participation in the study
- Have cognitive impairment that prevents appropriate use of the chat function
Target Size - 100
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2023 Year 12 Month 15 Day
Date of IRB - 2023 Year 12 Month 15 Day
Anticipated trial start date - 2026 Year 04 Month 01 Day
Last follow-up date - 2026 Year 06 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069679
Disclaimer: Curated by HT Syndication.
